bioweapons

How to stop bioterrorists from buying dangerous DNA

By Steph Batalis, Vikram Venkatram | Biosecurity

SAN FRANCISCO, CALIFORNIA - OCTOBER 03: OpenAI Co-Founder & CEO Sam Altman speaks onstage during TechCrunch Disrupt San Francisco 2019 at Moscone Convention Center on October 03, 2019 in San Francisco, California. (Photo by Steve Jennings/Getty Images for TechCrunch)

Apathy and hyperbole cloud the real risks of AI bioweapons

By Filippa Lentzos, Jez Littlewood, Hailey Wingo, Alberto Muti | Biosecurity

Catapulting corpses? A famous case of medieval biological warfare probably never happened

By Matt Field | Biosecurity

A US national labs researcher studying viruses.

How to tell biodefense from an offensive bioweapons program

By Dan Regan, Rhys Dubin | Biosecurity

Can a 1975 bioweapons ban handle today’s biothreats?

By Matt Field | Biosecurity

Russian ambassador to the United Nations.

Russia (again) peddles its debunked US-Ukrainian bioweapons claims at the United Nations

By Jez Littlewood, Filippa Lentzos | Biosecurity

Russia’s alleged bioweapons claims have few supporters

By Jez Littlewood, Filippa Lentzos | Biosecurity

Fear and Loathing in Moscow: The Russian biological weapons program in 2022

By Robert Petersen | Biosecurity

A monkeypox protest

The Strategic National Stockpile failed during COVID and monkeypox. Will it come through next time?

By Matt Field | Biosecurity

Russian ambassador to the United Nations.

Russia amplifies bioweapons claims at the United Nations Security Council

By Matt Field | Biosecurity

In Ukraine, US-military-linked labs could provide fodder for Russian disinformation

By Matt Field | Biosecurity

Representatives to the Biological Weapons Convention meet.

Don’t let finger-pointing doom this key treaty against bioweapons

By Filippa Lentzos, Jez Littlewood | Biosecurity